United Therapeutics Corporation balance sheet
At the end of its fiscal year on Dec 31, 2025, United Therapeutics Corporation reported total assets of $7.88B and shareholders' equity of $7.10B. That works out to liabilities equal to 10% of assets, a current ratio of 6.60 (current assets ÷ current liabilities).
Balance sheet at each fiscal year end
| Fiscal year ended | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $2.33B | $2.88B | $3.40B | $3.91B | $4.62B | $5.17B | $6.04B | $7.17B | $7.36B | $7.88B |
| Current assets | $1.42B | $1.45B | $1.77B | $1.86B | $2.17B | $2.32B | $3.38B | $3.55B | $3.87B | $3.70B |
| Cash & equivalents | $1.02B | $705.10M | $669.20M | $738.40M | $738.70M | $894.80M | $961.20M | $1.21B | $1.70B | $1.56B |
| Total liabilities | $463.40M | $758.40M | $593.20M | $1.13B | $1.22B | $1.21B | $1.25B | $1.18B | $920.00M | $783.80M |
| Current liabilities | $332.50M | $444.70M | $276.60M | $463.00M | $323.30M | $305.40M | $343.20M | $804.40M | $738.10M | $560.60M |
| Shareholders' equity | $1.85B | $2.10B | $2.79B | $2.78B | $3.40B | $3.96B | $4.80B | $5.98B | $6.44B | $7.10B |
| Reported in | 10-K 2018 | 10-K 2019 | 10-K 2020 | 10-K 2021 | 10-K 2022 | 10-K 2023 | 10-K 2024 | 10-K 2025 | 10-K 2026 | 10-K 2026 |
Balance-sheet figures are point-in-time values on the last day of each fiscal year. Some companies (for example banks and insurers) do not present current assets and liabilities; those cells show —.
Source: SEC EDGAR XBRL company facts for CIK 1082554 (raw data). Most recent filing in this dataset: 10-Q filed Aug 5, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.